ValueAct to Cut Stake in Valeant Pharmaceuticals (VRX); Vacates Board Seat

Mason Morfit, the chief executive officer of ValueAct Capital resigned as director of the board of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to be able to reduce the position of the activist hedge in the...

Facebook Inc (FB) Earnings Beat Analysts Estimates; Stock Soars

The shares of Facebook Inc (NASDAQ:FB) rebounded after reporting its first quarter earnings results to beat the consensus estimate of Wall Street analysts. The stock price of the company closed at $61.36 a share,...

Recent posts

Popular categories